Page last updated: 2024-10-16

carbamates and Acute Lung Injury

carbamates has been researched along with Acute Lung Injury in 2 studies

Acute Lung Injury: A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, L1
Zhou, X1
Shetty, S1
Hou, G1
Wang, Q1
Fu, J1
Finkin-Groner, E1
Moradov, D1
Shifrin, H1
Bejar, C1
Nudelman, A1
Weinstock, M1

Other Studies

2 other studies available for carbamates and Acute Lung Injury

ArticleYear
HDAC6 inhibition blocks inflammatory signaling and caspase-1 activation in LPS-induced acute lung injury.
    Toxicology and applied pharmacology, 2019, 05-01, Volume: 370

    Topics: Acetylation; Acute Disease; Acute Lung Injury; Animals; Anti-Inflammatory Agents; Carbamates; Caspas

2019
Indoline-3-propionate and 3-aminopropyl carbamates reduce lung injury and pro-inflammatory cytokines induced in mice by LPS.
    British journal of pharmacology, 2015, Volume: 172, Issue:4

    Topics: Acute Lung Injury; Animals; Carbamates; Cell Line; Cells, Cultured; Cholinesterases; Cytokines; Fema

2015